Literature DB >> 25347951

[Antithrombocytic therapy and PCI. Duration of therapy after DCB/stents/scaffolds].

B Scheller1.   

Abstract

The duration of dual antiplatelet therapy (DAPT) after percutaneous coronary interventions (PCI) depends on the type of intervention and the clinical situation of the patient. After angioplasty alone (plain old balloon angioplasty, POBA) DAPT is not yet established but does, however, make sense to continue for 4 weeks. The duration of DAPT after placement of bare metal stents (BMS) is 4 weeks, after drug-eluting stents (DES) 6 months, after bioresorbable vascular scaffold (BVS) systems 6-12 months and after drug-coated balloon catheters (DCB) without a new implant 4 weeks.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25347951     DOI： 10.1007/s00059-014-4158-2

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  28 in total

Review 1.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Authors:  Edoardo Camenzind; P Gabriel Steg; William Wijns
Journal:  Circulation       Date:  2007-03-07       Impact factor: 29.690

2.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

3.  Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease.

Authors:  Jochen Wöhrle; Ralf Birkemeyer; Sinisa Markovic; The-Vinh Nguyen; Anil Sinha; Tomislav Miljak; Jochen Spiess; Wolfgang Rottbauer; Harald Rittger
Journal:  Heart       Date:  2011-05-26       Impact factor: 5.994

4.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

Authors:  Roxana Mehran; Usman Baber; Philippe Gabriel Steg; Cono Ariti; Giora Weisz; Bernhard Witzenbichler; Timothy D Henry; Annapoorna S Kini; Thomas Stuckey; David J Cohen; Peter B Berger; Ioannis Iakovou; George Dangas; Ron Waksman; David Antoniucci; Samantha Sartori; Mitchell W Krucoff; James B Hermiller; Fayaz Shawl; C Michael Gibson; Alaide Chieffo; Maria Alu; David J Moliterno; Antonio Colombo; Stuart Pocock
Journal:  Lancet       Date:  2013-09-01       Impact factor: 79.321

5.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

6.  Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions.

Authors:  U Zeymer; M Waliszewski; M Spiecker; O Gastmann; B Faurie; M Ferrari; M Alidoosti; C Palmieri; T N Heang; P Jl Ong; U Dietz
Journal:  Heart       Date:  2013-11-26       Impact factor: 5.994

7.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

8.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

9.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Authors:  A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

10.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245
View more
  1 in total

1.  Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yong Zhu; Kesen Liu; Xiangyun Kong; Jing Nan; Ang Gao; Yan Liu; Hongya Han; Hong Li; Huagang Zhu; Jianwei Zhang; Yingxin Zhao
Journal:  Front Cardiovasc Med       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.